Clinical Trial Update: Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks [Phase 3]

View source ↗

Summary

Completed Phase 3 trial evaluating Treximet (sumatriptan/naproxen) for the acute treatment of multiple migraine attacks.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED